You are here

Uptravi

J&J aims to create community for PAH patients and their doctors with new Uptravi campaign

Fierce Pharma

Tue, 05/18/21 - 10:59 am

pharma marketing

EMA panel recommends that use of Actelion's Uptravi may continue

Yahoo/Reuters

Sat, 02/11/17 - 12:32 pm

pulmonary arterial hypertension

Looking ahead at orphan drugs' future: More breakthroughs, exploding sales

BioPharma Dive

Wed, 02/17/16 - 09:49 pm

Sumitomo Dainippon

obeticholic acid

Actelion sees Uptravi price of $160,000-170,000/patient

Yahoo/Reuters

Tue, 01/5/16 - 02:47 pm

pulmonary arterial hypertension

Actelion says selexipag to enter U.S. market in January

Yahoo/Reuters

Tue, 12/22/15 - 10:56 am

pulmonary arterial hypertension

Deep dive into Actelion's Uptravi data calms investors as FDA decision date nears

Fierce Biotech

Wed, 03/18/15 - 11:08 am

pulmonary arterial hypertension